PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.07 - 0.07
0.04 - 0.15
840.0K / 2.59M (Avg.)
-2.33 | -0.03
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.42%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-27.58%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
39.97%
EBIT growth below 50% of 8095.HK's 97.41%. Michael Burry would suspect deeper competitive or cost structure issues.
30.52%
Operating income growth under 50% of 8095.HK's 97.79%. Michael Burry would be concerned about deeper cost or sales issues.
16.54%
Net income growth under 50% of 8095.HK's 98.74%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.25%
EPS growth under 50% of 8095.HK's 98.75%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.25%
Diluted EPS growth under 50% of 8095.HK's 98.75%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.01%
Share count expansion well above 8095.HK's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.69%
Negative OCF growth while 8095.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-73.69%
Negative FCF growth while 8095.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
7.30%
Positive 10Y revenue/share CAGR while 8095.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-43.36%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-51.69%
Negative 3Y CAGR while 8095.HK stands at 1.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-39.61%
Negative 10Y OCF/share CAGR while 8095.HK stands at 156.31%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-306.99%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
50.91%
Positive 5Y CAGR while 8095.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-173.54%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
142.79%
10Y equity/share CAGR 1.25-1.5x 8095.HK's 122.83%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
-16.73%
Negative 5Y equity/share growth while 8095.HK is at 25.09%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.31%
Negative 3Y equity/share growth while 8095.HK is at 7.02%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.26%
Firm’s AR is declining while 8095.HK shows 1.17%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-37.46%
Inventory is declining while 8095.HK stands at 14.93%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
23.13%
Asset growth above 1.5x 8095.HK's 9.83%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-13.13%
We have a declining book value while 8095.HK shows 3.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
172.72%
Debt growth far above 8095.HK's 10.06%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-24.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.